Evidence map›Paper›PMID 38899739›Full record

ArticleBioanalysis2024

2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (

Olga Kholmanskikh, Yow-Ming Wang, Sarah Hersey, Meenu Wadhwa, Katherine Block, Abbas Bandukwala, Matthew Szapacs, Russell Weiner, Khader Awwad, Francis Dessy and 59 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioanalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Strategies for Multiplexing Plasmonic Biosensing.Sensors (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

69 authors.

Olga KholmanskikhBelgium FAMHP, Brussels, Belgium.
Yow-Ming WangUS FDA, Silver Spring, MD, USA.
Sarah HerseyBristol Myers Squibb, Lawrenceville, NJ, USA.
Meenu WadhwaUK MHRA, London, UK.
Katherine BlockGenentech, South San Francisco, CA, USA.
Abbas BandukwalaUS FDA, Silver Spring, MD, USA.
Matthew SzapacsAbbvie, Philadelphia, PA, USA.
Russell WeinerTakeda, Cambridge, MA, USA.
Khader AwwadAbbvie, Ludwigshafen, Germany.
Francis DessyGlaxoSmithKline, Rixensart, Belgium.
Sean DowningTakeda, Cambridge, MA, USA.
Xiulian DuUS FDA, Silver Spring, MD, USA.
Fabio GarofoloBRI Frontage, Vancouver, BC, Canada.
Shannon HarrisHilleVax, Cambridge, MA, USA.
Victor HouModerna, Cambridge, MA, USA.
Jennifer JonesBristol Myers Squibb, Lawrenceville, NJ, USA.
Sumit KarWRIB, Toronto, ON, Canada.
Arvind KinhikarNovartis, Cambridge, MA, USA.
Ming LiStoke, Cambridge, MA, USA.
Joel MathewsIonis, Carlsbad, CA, USA.
John MeissenAstraZeneca, South San Francisco, CA, USA.
Giane Oliveira SumnerRegeneron, Tarrytown, NY, USA.
Luying PanTakeda, Cambridge, MA, USA.
Gerard SanderinkSanofi Pasteur, Swiftwater, PA, USA.
Ingrid ScullyPfizer, Pearl River, NY, USA.
Johannes StantaCelerion, Stevenage, UK.
Yoichi TanakaJapan MHLW, Tokyo, Japan.
Stephanie VauleonF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Leslie WagnerUS FDA, Silver Spring, MD, USA.
Kai WangGlaxoSmithKline, Collegeville, PA, USA.
Liang ZhuModerna, Cambridge, MA, USA.
Steven EckAstraZeneca, Gaithersburg, MD, USA.
Yi-Dong LinTakeda, Cambridge, MA, USA.
Mitra AzadehUltragenyx, Cambridge, MA, USA.
Vilma DecmanGlaxoSmithKline, Collegeville, PA, USA.
Sandra DieboldUK MHRA, London, UK.
Xiulian DuUS FDA, Silver Spring, MD, USA.
Polina GoihbergPfizer, Andover, MA, USA.
Enrique Gomez AlcaideF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Christele GonneauLabcorp, Meyrin, Switzerland.
Michael Nathan HedrickBristol Myers Squibb, Lawrenceville, NJ, USA.
Gregory Hopkins2seventy Bio, Cambridge, MA, USA.
Sumit KarWRIB, Toronto, ON, Canada.
Jakob LoschkoPfizer, Pearl River, NY, USA.
Megan McCauslandQ2 Solutions, Atlanta. GA, USA.
Luis MendezMerck, Kenilworth, NJ, USA.
Sarita SehraIncyte, Wilmington, DE, USA.
Erin StevensPfizer, Groton, CT, USA.
Yongliang Steve SunBristol Myers Squibb, Lawrenceville, NJ, USA.
Shabnam TangriNavigate, a Novartis Subsidiary, San Diego, CA, USA.
Paul C TrampontModerna, Cambridge, MA, USA.
Isabelle CludtsUK MHRA, London, UK.
Mark DysingerAlexion, New Haven, CT, USA.
Uma KavitaSpark Therapeutics, Plainsboro, NJ, USA.
Hiroshi SugimotoTakeda, Cambridge, MA, USA.
Shannon ChilewskiBristol Myers Squibb, Lawrenceville, NJ, USA.
Christine GrimaldiRegeneron, Tarrytown, NY, USA.
Yong JiangGlaxoSmithKline, Collegeville, PA, USA.
John KamerudPfizer, Andover, MA, USA.
Susana LiuPfizer, Kirkland, QC, Canada.
Carolina OwenPfizer, Groton, CT, USA.
Nisha PalackalRegeneron, Tarrytown, NY, USA.
Corinne Petit-FrereFresenius Kabi, Bad Homburg, Germany.
Samuel PineSanofi, Ghent, Belgium.
Mohsen Rajabi AbhariUS FDA, Silver Spring, MD, USA.
Kara ScheibnerUS FDA, Silver Spring, MD, USA.
LaKenya WilliamsBristol Myers Squibb, Lawrenceville, NJ, USA.
Tao XuFrontage, Exton, PA, USA.
Guodong ZhangAlnylam, Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 17

Indexed as

BiomarkersCell- and Tissue-Based TherapyVaccinesBiological AssayEuropean UnionFlow CytometryHumansBiomarkersVaccinesbioanalysisbiomarkerscell therapygene therapyimmunogenicityvaccineWRIB

Identifiers

PMID38899739
PMCPMC11216500

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.